The company

About us

Cytoimmun Diagnostics GmbH is ISO 9001 and ISO 13485 certified.

We understand women's health as our ultimate goal and the preservation of their quality of life as our central task.

As a worldwide technologically leading provider of prognostic markers for HPV induced cervical carcinoma,

Cytoimmun Diagnostics GmbH located in Pirmasens brings significantly more certainty to a subject so far intransparent to

women: the risk to develop cervical cancer.

Our worldwide unique technology eliminates uncertainty and provides clarity by combining our methods with cancer

screening examination and cytology (Pap test). The result allows to predict simply and reliably whether a woman's HPV infection will result

in the development of tumors or not. Our technology is used by leading pathologists and cytologists on the basis of

extensive clinical studies.

Cytoimmun Diagnostics considers itself as a partner for gynecologists, cytologists, pathologists and corresponding lab

physicians concerned with this subject. Our primary self-conception, however, is to provide women affected by cell changes with fast and

uncomplicated clarity regarding their burdening situation and to prevent unnecessary excessive therapies and unnecessary not seldom associated there with.

surgical interventions